Welcome
- Welcome
- Map to UT-Health Science Campus
- Directory
- Faculty
- Personnel
- Postdoctoral Fellows
- Graduate Students
- Former Graduates
- Training in Medical Microbiology & Immunology
- News and Announcements
- Awards
- Newsletter
- Calendar of Events
- Core Facilities
- Flow Cytometry Core
- Job Openings
- Rocket Science
- Earl H. Freimer Award
Additional Information
Contact Us
Health Science Campus
MD Programs
419.383.4229
medadmissions@utoledo.edu
Graduate Programs
419.383.4112
grdsch@utnet.utoledo.edu
Mark Wooten, Ph.D.
![]() |
Associate Professor Host/Pathogen Interactions in Lyme Disease and Melioidosis E-mail: R.Mark.Wooten@utoledo.edu Telephone: 419.383.6818 Fax: 419.383.3002
BSL3 and ABSL3 Core Laboratory Director link to read Mark's article on Lyme Disease ...
|
|
Dr. Wooten's laboratory is interested in the host/pathogen interactions that lead
to the development of two different infectious diseases: Lyme disease and melioidosis.
Melioidosis is a human and animal disease that is caused by infection with Burkholderia pseudomallei, which is endemic within different tropical and subtropical regions worldwide. Acute disease can lead to fulminant septicemia with mortality rates of 40-90%, even with vigorous antibiotic and supportive therapy. Chronic disease can also develop, with recrudescence occurring months to years after initial exposure. While there are some predisposing factors that make certain human populations more susceptible to developing this disease (e.g. diabetes, alcohol abuse, renal disease, etc.), exposure to B. pseudomallei-containing aerosols is reported to have an LD50 ≤100 organisms in mice, thus giving it considerable potential for misuse as a biological weapon. This organism is also quite resistant to many classes of antibiotics and there is currently no vaccine. Thus there is great interest in identifying targets for preventative and/or curative treatments for these infections. Persistence within macrophages and other cell types appears to be central to the development of melioidosis, providing them an environment where they can proliferate and spread cell-to-cell via actin polymerization, thus enabling the bacteria to spread and evade humoral immune mediators. Relatively little is known about the molecular basis for B. pseudomallei virulence, but it appears that these bacteria quickly escape the phagosome and evade intracellular killing, preventing bacterial clearance and generation of an effective adaptive immune response. A better understanding of the basic biology of macrophage/phagocyte subversion by this bacterium would greatly facilitate the development of preventative and curative treatments. We are interested in utilizing the recently-developed murine model of melioidosis to address the following areas:
Dr. Wooten received his Bachelors (Zoology/Chemistry; 1985) and Masters (Microbiology/Immunology;
1990) from the University of Arkansas (Fayetteville) under the supervision of Dr.
Jim Saunders. He received his Ph.D. (Microbiology/Immunology; 1995) from the University
of Mississippi Medical Center under the supervision of Dr. Jan Bly. He completed post-doctoral
training at the University of Utah College of Medicine in the laboratory of Dr. Janis
Weis. Dr. Wooten joined the Department of Medical Microbiology and Immunology at the
University of Toledo College of Medicine in May 2001. -National Institutes of Health (U01) - Glanders Vaccine Development (co-PI) Bhat, A., R. M. Wooten, A. C. Jayasuriya. Secretion of growth factors from macrophages when culture with microparticles. 2013 (in press). J. Biomed. Mater. Res., Part A. Woodman, M. E. , R. G. Worth, and R. M. Wooten. 2012. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils. PLoS ONE 7(12):e52276 Riaz, A. R., B. E. Tasma, M. E. Woodman, R. M. Wooten, and R. G. Worth. 2012. Human platelets efficiently kill IgG-opsonized E. coli. FEMS Immunol Med Microbiol. 65:78-83. Lazarus, J. J., A. L. McCarter, and R. M. Wooten. 2012. ELISA-based measurement of antibody responses and PCR-based detection profiles can distinguish between active infection and early clearance of Borrelia burgdorferi. Clin Dev Immunol. 2012:138069. Balder, R., S. Lipski, J. J. Lazarus, W. Grose, R. M. Wooten, R. J. Hogan, D. E. Woods, and E. R. Lafontaine. 2010. Identification and characterization of Burkholderia mallei and B. pseudomallei adhesions for human respiratory epithelial cells. BMC Microbiol. 10:250-269. Woodman, M.E., Cooley, A.E., Avdiushko, R., Bowman, A., Botto, M., Wooten, R.M., van Rooijen, N., Cohen, D.A., Stevenson, B. (2009) Roles for phagocytic cells and complement in controlling relapsing fever infection. J Leukoc Biol. 2009 Sep; 86(3):727-736. Lazarus JJ, Kay MA, McCarter AL, Wooten RM. (2008) Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun. Mar;76:1153-1162. Woodman, M.E., Cooley, A.E., Miller, J.C., Lazarus, J.J., Tucker, K., Bykowski, T., Botto, M., Hellwage, J., R.M. Wooten*, and Stevenson, B.* (2007) Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection. Infect. Immun. 75:3131-3139. *These labs contributed equally to this manuscript. Lipski, S.L., Akimana, C., Timpe, J.M., Wooten, R.M., Lafontaine, E.R. (2007) The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain. Infect. Immun. 75:314-324. Crandall, H., Dunn, D.M., Ma, Y., Wooten, R.M., Zachary, J.F., Weis, J.H., Weiss, R.B., Weiss, J.J. (2006) Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J. Immunol. 177:7930-7942. Lazarus, J.J., Meadows, M.J., Lintner, R.E., Wooten, R.M. (2006) IL-10 Deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol. 177: 7076-7085. Melillo, A., Sledjeski, D.D., Lipski, S., Wooten, R.M., Basrur, V., Lafontaine, E.R. (2006) Identification of a Francisella tularensis LVS outer membrane protein that confers adherence to A549 human lung cells. FEMS Microbiol. Lett. 263:102-108. Lawrenz, M.B., Wooten, R.M., and Norris, S.T. (2004) Effects of vLsE Complementation on the Infectivity of Borrelia burgdorferi Lacking the Linear Plasmid Ip28-1. Infect. Immun., 72:6577-6585. Lawrenz, M.B., Wooten, R.M., Zachary, J.F., Drouin, S.M., Weis, J.J., Wetsel, R.A., and Norris, S.J. (2003) Effect of Complement Component C3 Deficiency on Experimental Lyme Borreliosis in Mice. Infect. Immun., 71:4432-4440. Yoder A., Wang X., Ma Y., Philipp, M. T., Heilbrun, M., Weis, J. H., Kirschning, C. J., Wooten, R. M., and Weis, J. J.(2003) Tripalmitoyl-S-Glyceryl-Cysteine-Dependent OspA Vaccination of Toll-Like Receptor 2-Deficient Mice Results in Effective Protection from Borrelia burgdorferi Challenge. Infect. Immun., 71:3894-3900. Wooten, R. M., Ying, M. A., Yoder, R. A., Brown, J. P., Weis, J. H., Zachary, J. F., Kirschning, C. J., and Weis, J. J.(2002) Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. Vector Borne Zoonotic Dis, 2:275-278. Wooten, R.M., Ma, Y., Yoder, R. A., Brown, J. P., Weis, J. H., Zachary, J. F., Kirschning, C.
J., and Weis, J. J. (2002) Toll-like receptor 2 is required for innate, but not acquired, host defense
to Borrelia burgdorferi. J. Immunol.,168:348-355. Wooten, R. M. and Weis, J. J. (2001) Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr. Opin. Micro., 4:274-279. Brown, E. L., Wooten, R. M., Johnson, B. J., Iozzo, R. V., Smith, A., Dolan, M.C., Guo, B. P., Weis, J. J., and
Hook, M.(2001) Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest., 107:845-852. Brown, J. P., Zachary, J. F., Teuscher, C., Weis, J. J., and Wooten, R. M. (1999) Dual role of IL-10 in murine Lyme disease: Regulation of arthritis severity and host defense. Infect. Immun., 67:5142-5150. Hirschfeld, M., Kirschning, C. J., Schwandner, R., Wesche, H., Weis, J. H., Wooten, R. M., and Weis, J. J. (1999) Cutting Edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol., 163:2382-2386. Wooten, R. M., Morrison, T. B., Weis, J. H., Wright, S. D., Thieringer, R., and Weis, J. J. (1998) The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol., 160:5485-5492. Wooten, R. M., Cutchens, M. A., Causey, A. L., Clem, L. W., and Bly, J. E. (1997) Effects of oleic acid on murine CD4+ T cell death and anti-CD3 or superantigen induced proliferation at low temperature. Dev. Comp. Immunol., 21:375-384. Wooten, R. M., Modur, V. R., McIntyre, T. M., and Weis, J. J. (1996) Borrelia burgdorferi outer membrane protein A (OspA) induces nuclear translocation of NF-kB and inflammatory activation in human endothelial cells. J. Immunol.,157:4584-4590. Causey, A. L., Wooten, R. M., Cuchen, M. A., Clem, L. W., and Bly, J. E. (1996) Anergy or cell death induced by
low physiological temperature in mitogen-stimulated human T lymphocytes. J. Therm.
Biology., 21:381-388. Lipski, S.L., Akimana, C., Timpe, J.M., Wooten, R.M., Lafontaine, E.R. (2007) The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain. Infect. Immun. 75:314-324. Crandall, H., Dunn, D.M., Ma, Y., Wooten, R.M., Zachary, J.F., Weis, J.H., Weiss, R.B., Weiss, J.J. (2006) Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis. J. Immunol. 177:7930-7942. Lazarus, J.J., Meadows, M.J., Lintner, R.E., Wooten, R.M. (2006) IL-10 Deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol. 177: 7076-7085. Melillo, A., Sledjeski, D.D., Lipski, S., Wooten, R.M., Basrur, V., Lafontaine, E.R. (2006) Identification of aFrancisella tularensis LVS outer membrane protein that confers
adherence to A549 human lung cells. FEMS Microbiol. Lett. 263:102-108. Yoder A., Wang X., Ma Y., Philipp, M. T., Heilbrun, M., Weis, J. H., Kirschning, C. J., Wooten, R. M., and Weis, J. J. (2003) Tripalmitoyl-S-Glyceryl-Cysteine-Dependent OspA Vaccination of Toll-Like Receptor 2-Deficient Mice Results in Effective Protection from Borrelia burgdorferi Challenge. Infect. Immun., 71:3894-3900. Wooten, R. M., Ying, M. A., Yoder, R. A., Brown, J. P., Weis, J. H., Zachary, J. F., Kirschning, C. J., and Weis, J. J. (2002) Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. Vector Borne Zoonotic Dis, 2:275-278. Wooten, R.M., Ma, Y., Yoder, R. A., Brown, J. P., Weis, J. H., Zachary, J. F., Kirschning, C.
J., and Weis, J. J. (2002) Toll-like receptor 2 is required for innate, but not acquired, host defense
to Borrelia burgdorferi. J. Immunol., 168:348-355. Causey, A. L., R. M. Wooten, L. W. Clem, and J. E. Bly. 1994. A defined serum-free medium for human primary T cell culture. J. Immunol. Methods 175:115-121. Wooten, R. M., L. W. Clem, and J. E. Bly. 1993. The effects of temperature and oleic acid on murine memory and virgin T cell activation: interleukin-2 secretion and interleukin-2 receptor expression. Cell. Immunol. 152:35-48. |
|
UT Virtual View Book
UT Rockets
A University Rising
UTMC Named Regions #1 Hospital

